TERN-701 / Jiangsu Hansoh Pharma, Terns Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TERN-701 / Terns Pharma
CARDINAL, NCT06163430: - A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia

Not yet recruiting
1
80
US
TERN-701
Terns, Inc.
Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia
11/25
05/26
NCT05367700: A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

Recruiting
1
108
RoW
HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion)
Jiangsu Hansoh Pharmaceutical Co., Ltd.
CML, Chronic Phase, CML, Accelerated Phase
12/24
09/26

Download Options